Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on ASTELLAS PHARMA INC
02/16 ASTELLAS PHARMA : Recent Findings from Astellas Pharma, Inc. Advance Knowledge i..
02/16 ASTELLAS PHARMA : Studies from Astellas Pharma, Inc. Have Provided New Data on H..
02/16 ASTELLAS PHARMA : Researchers from Astellas Pharma, Inc. Report Recent Findings ..
02/16 ASTELLAS PHARMA : Reports from Astellas Pharma, Inc. Advance Knowledge in Antire..
02/16 ASTELLAS PHARMA : Recent Findings in Antifungals Described by Researchers from A..
02/09 ASTELLAS PHARMA : Details Findings in Immunoglobulins (Investigation of Hydrophi..
02/09 ASTELLAS PHARMA : and Ironwood Report Positive Top-Line Results from Phase III L..
02/09 ASTELLAS PHARMA : Announces Changes in Management tructure and lobal unction
02/09 ASTELLAS PHARMA : Announces Personnel Changes and Organizational Changes
02/09 ASTELLAS PHARMA : Names Linda Friedman General Counsel for Worldwide Legal Organ..
02/08 ASTELLAS PHARMA : Announces Changes in Management Structure and Global Function ..
02/08 ASTELLAS PHARMA : Announces Personnel Changes and Organizational Changes (pdf 39..
02/02 ASTELLAS PHARMA : Improves Rank in Second Year Named to Corporate Knights' 2017 ..
02/02 ASTELLAS PHARMA : US Executive Interview Series - Dr. David Stover
02/01 ASTELLAS PHARMA : Announces Acquisition of Own Shares
01/31 ASTELLAS PHARMA : Reports the First Nine Months Financial Results of FY2016
01/31 ASTELLAS PHARMA : Executes License Agreement with Auration Biotech for the Devel..
01/31 ASTELLAS PHARMA : Reports the First Nine Months Financial Results of FY2016 (pdf..
01/31 ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 190KB)
01/30 IRONWOOD PHARMACEUTICALS : Astellas And Ironwood Report Positive Results From Ph..
01/26 REPORTS FROM ASTELLAS PHARMA, INC. D : a novel antifungal agent produced by Acre..
01/26 ASTELLAS PHARMA : Researchers from Astellas Pharma, Inc. Provide Details of New ..
01/20 ASTELLAS PHARMA : Improves Rank in Second Year Named to Corporate Knights' 2017 ..
01/19 ASTELLAS PHARMA : Improves Rank in Second Year Named to Corporate Knights’..
01/18 ASTELLAS PHARMA : Announces Participation in Access Accelerated - Builds on Comp..
01/12 ASTELLAS PHARMA : Launches Second Phase of Global Campaign on CNN
01/10 ASTELLAS PHARMA : Terminates Agreement with UMN Pharma for Cell Culture Based In..
2016 ASTELLAS PHARMA : Completes Acquisition of Ganymed Pharmaceuticals
2016 ASTELLAS PHARMA : to Present at J.P. Morgan Healthcare Conference
2016 ASTELLAS PHARMA : Announces FDA Fast Track Designation for ASP0892, DNA Vaccine ..
2016 ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares
2016 ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares
2016 ASTELLAS PHARMA : to Present at J.P. Morgan Healthcare Conference
2016 AMGEN : seeks to market osteoporosis drug in Japan
2016 ASTELLAS PHARMA : New Cell Proliferation Study Findings Recently Were Reported b..
2016 PFIZER : and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTAN..
2016 ASTELLAS PHARMA : Oncorus®, Inc. Announces Additional Series A Financing Support..
2016 ASTELLAS PHARMA : Completes Acquisition of Ganymed Pharmaceuticals
2016 ASTELLAS PHARMA : Marketing Approval of LINZESS, Treatment for Irritable Bowel S..
2016 ASTELLAS PHARMA : Amgen astellas and astellas announce submission of application..
2016 ASTELLAS PHARMA : Announces FDA Fast Track Designation for ASP0892, DNA Vaccine ..
2016 ASTELLAS PHARMA : Marketing Approval of LINZESS®, Treatment for Irritable Bowel ..
2016 PFIZER : and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTAN..
2016 ASTELLAS PHARMA : Sysmex, Astellas and Daiichi Sankyo Sign Memorandum of Underst..
2016 ASTELLAS PHARMA : Pfizer and Astellas Announce Top-Line Results from Phase 4 PLA..
2016 ASTELLAS PHARMA : Multi-national pharma company reduces raw materials QC costs b..
2016 ASTELLAS PHARMA : Research & Development Meeting Highlights
2016 ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares
2016 ASTELLAS PHARMA : Immunomic Therapeutics Announces Expansion of IP Portfolio
2016 ASTELLAS PHARMA : Initiatives to Pursue Operational Excellence
2016 CASE STUDY : Application of SORS (RapID) to In-Container Testing of Raw Material..
2016 ASTELLAS PHARMA : Antihypertensive Drug 'Micatrio Combination Tablets'
2016 ASTELLAS PHARMA : Antihypertensive Drug "Micatrio® Combination Tablets"
2016 ASTELLAS PHARMA : GUINNESS WORLD RECORDS Title Achieved for Organ Donor Registra..
2016 ASTELLAS PHARMA : GUINNESS WORLD RECORDSTM Title Achieved for Organ Donor Regist..
2016 ASTELLAS PHARMA : FDA Approves Supplemental New Drug Application for XTANDI enza..
2016 ASTELLAS PHARMA : to Acquire Ganymed Pharmaceuticals
2016 ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares (pdf 187KB)
2016 ASTELLAS PHARMA : Announces Acquisition of Own Shares
2016 ASTELLAS PHARMA : to acquire German pharmaceutical company
2016 ASTELLAS PHARMA : to acquire German pharmaceutical company
2016 ASTELLAS PHARMA : Reports First Half FY2016 Financial Results, Revises Fiscal Ye..
2016 ASTELLAS PHARMA : to Acquire Ganymed Pharmaceuticals -Acquisition Would Expand '..
2016 ASTELLAS PHARMA : Reports First Half FY2016 Financial Results, Revises Fiscal Ye..
2016 ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 175KB)
2016 ASTELLAS PHARMA : Findings in Kidney Function Reported from Astellas Pharma, Inc..
2016 ASTELLAS PHARMA : FDA Approves Supplemental New Drug Application for XTANDI (enz..
2016 ASTELLAS PHARMA : FDA Approves Supplemental New Drug Application for XTANDI in A..
2016 ASTELLAS PHARMA : Launches Global Campaign in Collaboration with CNN as Part of ..
2016 ASTELLAS PHARMA : Launches Global Campaign in Collaboration with CNN as Part of ..
2016 ASTELLAS PHARMA : World Anti-Doping Agency and Astellas Announce Global Initiati..
2016 ASTELLAS PHARMA : Termination of Business Transfer Discussion with Kaketsuken
2016 INSPYR THERAPEUTICS, INC. (OTCQB : NSPX) Files An 8-K
2016 ASTELLAS PHARMA : World Anti-Doping Agency and Astellas Announce Global Initiati..
2016 ASTELLAS PHARMA : World Anti-Doping Agency and Astellas Announce Global Initiati..
1  2  3  4  5  6  7Next
Advertisement
Financials ( JPY)
Sales 2017 1 327 099 M
EBIT 2017 275 000 M
Net income 2017 203 446 M
Finance 2017 465 287 M
Yield 2017 2,23%
P/E ratio 2017 15,88
P/E ratio 2018 15,17
EV / Sales 2017 2,15x
EV / Sales 2018 1,98x
Capitalization 3 323 349 M
More Financials
Chart ASTELLAS PHARMA INC
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Full-screen chart
Technical analysis trends ASTELLAS PHARMA INC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 1 847  JPY
Spread / Average Target 20%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Yoshihiko Hatanaka President, CEO & Representative Director
Masafumi Nogimori Chairman
Yasumasa Masuda Chief Financial Officer
Mitsunori Matsuda Senior Executive Officer & President-Technology
Yoshiro Miyokawa Representative Director & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ASTELLAS PHARMA INC-6.95%29 442
JOHNSON & JOHNSON3.17%323 362
ROCHE HOLDING LTD.4.69%210 814
PFIZER INC.3.51%204 018
NOVARTIS AG3.91%202 998
MERCK & CO., INC.11.08%180 289
More Results